Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillance.
Cancer Sci
; 112(11): 4692-4701, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-34431585
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Product Surveillance, Postmarketing
/
Carcinoma, Non-Small-Cell Lung
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Lung Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Cancer Sci
Year:
2021
Type:
Article
Affiliation country:
Japan